E4 modifies the associations of polymorphisms in angiotensin-converting enzyme (ACE), which plays a key role in COVID-19 (3), with neuropsychiatric syndromes in Alzheimer’s disease (AD) (4). This evidence concerns the gene ACE and early-onset autosomal dominant Alzheimer disease.